POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
High Impact

New Jersey bill requires clinical independence for physicians and dentists and mandates transaction transparency

Original title: Establishes "Health Care Clinical Independence and Transaction Transparency Act."

Last action · October 19, 2026: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens CommitteeSponsor: Troy Singleton

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

This bill prohibits nonprofessional entities, including private equity firms, from exercising over the clinical judgment of licensed physicians, dentists, or professional practices. It requires professional practices to give 60 days' advance notice to the Attorney General and Commissioner of Health and post on their website for material transactions valued at $25 million or more, combined revenues of $25 million or more, or involving 10 or more New Jersey practitioners. The measure also protects reporting practitioners from retaliation and establishes civil penalties for noncompliance.

Why it matters

The measure directly affects healthcare practices, private equity investors, management services organizations, and licensed medical and dental professionals in New Jersey by altering how corporate entities can structure business agreements, manage clinical operations, and execute corporate transactions.

Background
  • State legislatures across the country have increasingly pursued regulatory oversight of private equity investments and corporate acquisitions in physician and dental practices. context

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Licensed physicians and dentists

Licensed practitioners gain legally protected ultimate authority over clinical decisions and are explicitly shielded from retaliatory action for reporting violations.

Directly affected

Private equity companies and significant equity investors

Investors face mandatory 60-day notice requirements for large-scale transactions, restrictions on exercising clinical control, and potential civil penalties for noncompliance.

Directly affected

Management services organizations

MSOs are prohibited from exercising de facto control over professional clinical judgment while remaining permitted to handle administrative and business functions.

Directly affected

Attorney General and Commissioner of Health

State regulators are tasked with receiving transaction notices, establishing implementing regulations, and overseeing post-transaction impacts and enforcement actions.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What business functions can nonprofessional entities still manage under this bill?
Nonprofessional entities are permitted to manage accounting, bookkeeping, payroll, nonclinical human resources, cybersecurity, real estate, billing administration, revenue-cycle management, marketing, and other business functions, provided licensed professionals retain ultimate clinical authority.
What transactions trigger the 60-day advance notice requirement?
Notice is required for material transactions valued at $25 million or more, transactions where the combined New Jersey revenue of the parties is $25 million or more, or transactions resulting in the acquisition or control of a practice involving 10 or more licensed physicians or dentists in the State.
What protections are provided for physicians and dentists who report violations?
The bill prohibits professional practices from taking retaliatory action against any licensed physician or dentist who in good faith refuses a directive believed to violate the act, reports a violation internally or to state authorities, or participates in an investigation.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Oct 19, 2026SenateIntroduced
    Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Expanded State Oversight of Private Equity in Healthcare

The measure establishes mandatory transaction reporting and clinical control prohibitions aimed at private equity-backed healthcare practices.

Connected Entities

New Jersey State Board of Dentistry, State Board of Medical Examiners, Attorney General and 4 more
OrganizationNew Jersey State Board of Dentistry“Consulted in the adoption of rules and regulations to implement the act”Map →
OrganizationState Board of Medical Examiners“Consulted in the adoption of rules and regulations to implement the act”Map →
OrganizationAttorney General“State official receiving transaction notices and enforcing compliance”Map →
PersonTroy Singleton“Primary sponsor of Senate Bill No. 4844 representing District 7 (Burlington)”Map →
OrganizationSuperior Court, Law Division“Court where the Attorney General may file enforcement and remedial actions”Map →
OrganizationDepartment of Health“State department consulting on rules, regulations, and transaction impacts”Map →
OrganizationCommissioner of Health“State official receiving transaction notices and monitoring post-transaction imp”Map →

Sources

Open source document

njleg.state.nj.us

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy60
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz40
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record